2023 annual financial data
Cellyan Biotechnology 2023 Net income growth
Direct answer
Net income growth was Not calculable.
Operating income was 1,043,793 USD and net income was 998,196 USD.
Operating cash flow was 1,727,079 USD.
Get free Cellyan Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,555,991 USD
- Operating income
- 1,043,793 USD
- Net income
- 998,196 USD
- Operating cash flow
- 1,727,079 USD